Things are so quite on here I should like to comment on your post Yankee
2. Q2 CY 2016 starts on 1/4/16 but runs to 30/6/16 and as MSB and these things generally take longer than shorter time frames I don't really expect a report till July or later. It's only a planned date not an absolute in concrete date. Love it to be sooner of course but the real boom will be the content, of which I am confident, rather than the date.
BTW, I'm fuzzy on the reduction in CHF trial nos. Originally the P3 Trial was of 1730 then it was reduced to 1165 with a confirmatory study of c500 (presentation August 15 Results) and further reduced to 600 but with SECOND confirmatory study of up to 600! (Presentation 20Feb 16)- much the same in total nos? Comments to explain would be much appreciated.
Cheers
To those holding this down, page-15
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |